BREAKING NEWS: In a stunning market development, shares of 4DMedical Ltd (ASX: 4DX) have skyrocketed by 665% in just two months, transforming a $10,000 investment into an astonishing $76,521! This meteoric rise comes as the respiratory imaging technology firm rapidly gains traction among investors.
Since the close of trading on July 9, 2023, the All Ordinaries Index (ASX: XAO) has recorded a modest 4.0% increase. However, 4DMedical has outpaced those gains dramatically. On July 9, shares were priced at a mere 23 cents, allowing investors to acquire 43,478 shares. As of last Friday, shares closed at $1.76 each, marking a phenomenal surge.
What is driving this remarkable growth? Over the past two months, 4DMedical has unveiled a series of significant milestones that have captivated investor interest. On August 1, 2023, shares jumped by 27.1% following a major investment of $10 million from health imaging leader Pro Medicus Ltd (ASX: PME). CEO Andreas Fouras stated, “
Pro Medicus is a global leader in healthcare, and we are thrilled to receive their support at this pivotal moment in our journey.
”
Fast forward to September 1, 2023, and shares soared by 36.0% after the company announced it had received clearance from the United States Food and Drug Administration (FDA) for its innovative CAT scan-based software, CT:VQ. Just two days later, on September 3, 2023, shares surged another 50.0% after the Centers for Medicare & Medicaid Services (CMS) confirmed reimbursement for CT:VQ at a rate of $650.50 per scan, effective immediately.
The momentum didn’t stop there. On September 8, 2023, shares climbed by 49.5% after the announcement of new agreements with Royal Melbourne Hospital, Spectrum Medical Imaging, and AstraZeneca to deploy its lung health analysis software.
This surge not only underscores the excitement surrounding 4DMedical’s potential but also highlights the growing demand for innovative healthcare solutions. Investors are keenly watching to see if this trend continues, as the company prepares to capitalize on its recent successes.
WHAT TO WATCH FOR: With 4DMedical set to launch its groundbreaking CT:VQ software, the market is buzzing with anticipation. As the healthcare sector adapts to new technologies, this stock could become a focal point for investors looking to capitalize on the next wave of innovation in medical imaging.
Stay tuned for more updates as this story develops and keep an eye on 4DMedical’s performance in the coming weeks.
